PRCT (STOCKS)
PROCEPT BioRobotics Corporation Common Stock
$22.000000
+0.750000 (+3.53%)
Prev close: $21.250000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Larry L. Wood
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,455.45M
- Employees
- 756
- P/E (TTM)
- -11.27
- P/B (TTM)
- 3.58
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
8
Buy
8
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.47 | $-0.47 | -0.0039 | -0.84% |
|
Mar 2026 (Q1)
|
$-0.56 | $-0.57 | +0.0076 | +1.34% |
|
Dec 2025 (Q4)
|
$-0.53 | $-0.33 | -0.1993 | -60.27% |
|
Sep 2025 (Q3)
|
$-0.38 | $-0.42 | +0.0398 | +9.48% |
Financial Statements
| Revenues | $337.34M |
| Benefits Costs and Expenses | $639.52M |
| Cost Of Revenue | $120.70M |
| Costs And Expenses | $441.55M |
| Gross Profit | $216.65M |
| Operating Expenses | $330.88M |
| Selling, General, and Administrative Expenses | $252.07M |
| Research and Development | $78.81M |
| Operating Income/Loss | -$114.23M |
| Income/Loss From Continuing Operations After Tax | -$109.76M |
| Income/Loss From Continuing Operations Before Tax | -$302.17M |
| Income Tax Expense/Benefit | $152.00K |
| Net Income/Loss | -$109.76M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$109.76M |
| Net Income/Loss Available To Common Stockholders, Basic | -$109.76M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.94 |
| Diluted Earnings Per Share | -$1.94 |
| Basic Average Shares | 112,695,000 |
| Diluted Average Shares | 112,695,000 |
| Assets | $479.35M |
| Current Assets | $420.29M |
| Inventory | $77.06M |
| Other Current Assets | $343.22M |
| Noncurrent Assets | $59.07M |
| Fixed Assets | $31.83M |
| Other Non-current Assets | $27.24M |
| Liabilities | $139.28M |
| Current Liabilities | $64.20M |
| Accounts Payable | $15.07M |
| Other Current Liabilities | $49.13M |
| Noncurrent Liabilities | $75.09M |
| Long-term Debt | $51.72M |
| Other Non-current Liabilities | $23.37M |
| Equity | $340.07M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $340.07M |
| Liabilities And Equity | $479.35M |
| Net Cash Flow From Operating Activities | -$74.34M |
| Net Cash Flow From Operating Activities, Continuing | -$74.34M |
| Net Cash Flow From Investing Activities | -$10.59M |
| Net Cash Flow From Investing Activities, Continuing | -$10.59M |
| Net Cash Flow From Financing Activities | $10.24M |
| Net Cash Flow From Financing Activities, Continuing | $10.24M |
| Net Cash Flow | -$74.69M |
| Net Cash Flow, Continuing | -$74.69M |
| Comprehensive Income/Loss | -$109.59M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$109.59M |
| Other Comprehensive Income/Loss | -$109.59M |